These prespecified analyses considered factors such as age, hypertension, heart failure, eGFR, proteinuria, new users after the index day, enrollee after 2006 and concurrent usage of other medications for glycemic control, and renin-angiotensin-aldosterone system (RAAS) blockers
Several groups have designed monomeric dual and triple agonists based on the interactions of GLP-1 with glucagon 54,55,56 and/or GIP 57,58,59
A reasonable person reading that paragraph in 1998 would conclude that shutting glucagon off - blocking the receptor - would be a useful diabetes therapy
Rare in the trials, but a recognised concern with GLP-1 medications generally, partly because rapid weight loss itself can trigger gallstones
Oral GLP-1 medications for weight loss, specifically Wegovy and Foundayo, are available direct-to-consumers with cash prices starting at $149 per month for the lowest doses
Kailera plans to begin global Phase 3 trials of HRS9531 as KAI-9531 evaluating multiple doses, including 8 mg and 10 mg, and longer treatment durations by year-end 2025